Dr. Akshay Jain has actively participated as the local site primary investigator for the following Clinical Phase III/ IV studies using novel medications/devices for treatment of diabetes, obesity, cardiovascular disease and elevated cholesterol.

  • PIONEER REAL: Real world outcome study with oral semaglutide (National PI)
  • PREFER CA: Real world outcome study with flash glucose monitoring in basal insulin
  • SPOT FIRST: Real world outcome with flash glucose monitoring prior to specialist appointment
  • SURE: Real world outcome study with Semaglutide
  • REALISE-DM: Real world outcome on switching from liraglutide/dulaglutide to semaglutide
  • GLITTER: Real world outcome using retrospective flash glucose monitoring
  • DECLARE- TIMI: MACE outcome study with Dapagliflozin
  • CAMELLIA: MACE outcome study with Lorcaserin
  • SERTUS: Active comparator efficacy study with Ertugliflozin
  • CANNON: Albuminuria study with Canagliflozin in DM-1
  • REWIND: MACE outcome study with Dulaglutide
  • SPIRE 1 &2: Cardiovascular outcome study with Bococizumab
  • LEXICON: Insulin dose outcome study with Sotagliflozin in DM-1
  • EASE-2: Safety and Tolerability study with Empagliflozin in DM-1
  • CANCARE: Prospective registry database study with Canagliflozin
  • ONSET 8: Randomized controlled trial with insulin Degludec and Faster acting Insulin Aspart in DM-1
  • GOAL RCT: Randomized controlled trial comparing effect of colesevelam versus ezetimibe as add-on to HMG CoA Reductase inhibitor therapy in DM-2



Dr. Akshay Jain, Endocrinologist , Surrey is on a mission to educate patients on their Nutritional and exercise options in relationship to Diabetes.

We look at Diabetes holistically by providing balanced information on treatment methods, nutrition and local practitioners.

Let us do the research for you. Sign up today!